论文部分内容阅读
目的研究缺血性脑卒中急性期(AIS)的检验方法 ,进而指导临床治疗。方法 50例AIS患者作为急性期组;同期50例缺血性脑卒中恢复期患者作为恢复期组;同期50例健康体检身体健康、既往无缺血性脑卒中病史者作为对照组。利用免疫透射比浊法检测尿微量白蛋白(MAU),分析研究结果。结果三组男女比例及年龄比较,差异无统计学意义(P>0.05);急性期组MAU阳性率明显高于恢复期组及对照组,差异具有统计学意义(P<0.01);恢复期组MAU阳性率明显多于对照组,差异具有统计学意义(P<0.01)。各组不同MAU水平所占例数比较,差异有统计学意义(P<0.05)。结论 MAU的异常可提示AIS患者病因多为动脉粥样硬化,可依据此开展治疗。
Objective To study the method of testing the acute phase of ischemic stroke (AIS) and to guide the clinical treatment. Methods Fifty patients with AIS were enrolled as acute group. Fifty patients with convalescent ischemic stroke were enrolled in the same period as the recovery group. Fifty healthy people in the same period were in good health. None of the previous ischemic stroke patients served as the control group. Urine microalbumin (MAU) was detected by immunoturbidimetry and the results were analyzed. Results There was no significant difference in age and sex between the three groups (P> 0.05). The positive rate of MAU in acute stage was significantly higher than that in recovery stage and control group (P <0.01) MAU positive rate was significantly more than the control group, the difference was statistically significant (P <0.01). The MAU level of each group accounted for the number of cases, the difference was statistically significant (P <0.05). Conclusions The abnormality of MAU may indicate that the cause of AIS is mostly atherosclerosis, and the treatment can be based on this.